市場調査レポート
商品コード
1291590
カプセル市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測Empty Capsules Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
カプセル市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測 |
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2~3営業日
|
世界のカプセルの市場規模は、2022年に28億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に7.5%の成長率(CAGR)を示し、2028年までに45億米ドルに達すると予測しています。
カプセルは、顆粒やペレットなど様々な剤形で患者の体内に投与される医薬品を安定した殻に封入したものを指します。ゼラチンカプセルと非ゼラチンカプセルの2種類で市販されています。ゼラチンカプセル(ハード、ソフト)は、豚の肉や牛・鶏の結合組織から製造される高コラーゲンの動物性医薬品です。一方、非ゼラチンカプセル(ベジタリアンカプセル)は、デンプンとヒドロキシプロピルメチルセルロース(HPMC)のブレンドから製造されています。現在、カプセルはヘルスケアや治療用途に幅広く使用されています。
心血管疾患や慢性疾患の有病率の増加、老年人口の増加は、カプセル市場の成長を促進する主な要因の一部です。これに伴い、カプセルの投薬を受けていない患者の胃腸の安全性を確保するためのカプセルインカプセル技術の導入も、成長を促す要因となっています。さらに、抗菌剤、制酸剤、吸入剤、栄養補助食品、鎮痛剤、抗生物質など、さまざまな医薬品を製造するメーカーによる即時放出カプセルの需要の高まりが、市場成長に寄与しています。ヘルスケア産業の急速な拡大や、適度な強度、透明性、耐油・耐脂性を持つヒドロキシプロピルメチルセルロース(HPMC)などの非ゼラチンカプセルの普及が、市場成長の推進力となっています。さらに、革新的な治療薬や医薬品を導入するためのヘルスケア分野における研究開発活動への投資が増加していることも、市場の成長を積極的に促進しています。その他、先進的な治療法へのアクセスが容易であること、カプセル供給業者とゼラチン製造業者の戦略的提携、各種栄養補助食品、免疫力向上剤、医薬品への需要の高まりなどが、市場に明るい展望を生み出しています。
The global empty capsules market size reached US$ 2.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2028, exhibiting a growth rate (CAGR) of 7.5% during 2023-2028.
Empty capsules refer to a stable shell encapsulating medicines that are administered in the patient's body in various dosage forms, such as granules and pellets. They are commercially available in two varying types, gelatin and non-gelatin. The gelatin capsules (hard and soft) are a high collagen animal-based medicine manufactured from pig meat and beef and chicken connective tissues. On the other hand, the non-gelatin, or vegetarian capsule, is produced from the blend of starch and hydroxypropyl methylcellulose (HPMC). Currently, empty capsules find extensive applications in healthcare and therapeutic applications.
The increasing prevalence of cardiovascular and chronic diseases and the rising geriatric population are some of the key factors driving the empty capsule market growth. In line with this, the introduction of capsule-in-capsule technology to ensure gastrointestinal safety of those patients that did not receive capsule medication is another growth-inducing factor. Moreover, the rising demand for the immediate-release capsule by manufacturers for producing various medicinal products, such as antibacterial, antiacids, inhalers, dietary supplements, painkillers, and antibiotics, are contributing to the market growth. The rapid expansion in the healthcare industry and the widespread adoption of non-gelatin capsules, such as hydroxypropyl methylcellulose (HPMC) due to its moderate strength, transparency, and resistance to oil and fat properties, are propelling the market growth. Additionally, the increasing investments in the research and development (R&D) activities in the healthcare sector for introducing innovative therapeutics and pharmaceutical drugs is positively stimulating the market growth. Other factors, such as the easy access to advanced treatment options, strategic collaborations between the empty capsule suppliers and gelatin manufacturers, and the growing demand for various dietary supplements, immunity boosters, and drugs, are creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global empty capsules market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, raw material, functionality, therapeutic application and end user.
Gelatin Capsule
Non-gelatin Capsule
Pig Meat
Bovine Meat
Bone
Hydroxypropyl Methylcellulose (HPMC)
Others
Immediate-release Capsules
Sustained-release Capsules
Delayed-release Capsules
Antibiotic and Antibacterial Drugs
Vitamins and Dietary Supplements
Antacid and Antiflatulent Preparations
Cardiovascular Therapy Drugs
Others
Pharmaceutical Industry
Nutraceutical Industry
Cosmetics Industry
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being ACG Associated Capsules Pvt. Ltd., Bright Pharma Caps Inc., CapsCanada Corporation, HealthCaps India Limited, Lonza Group AG, Medicaps Limited, Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation), Nectar Lifesciences Limited, Roxlor LLC, Shanxi Guangsheng Medicinal Capsules Co. Ltd, Snail Pharma Industry Co. Ltd, Suheung Co. Ltd and Sunil Healthcare Limited.
Key Questions Answered in This Report
1. What was the size of the global empty capsules market in 2022?
2. What is the expected growth rate of the global empty capsules market during 2023-2028?
3. What are the key factors driving the global empty capsules market?
4. What has been the impact of COVID-19 on the global empty capsules market?
5. What is the breakup of the global empty capsules market based on the type?
6. What is the breakup of the global empty capsules market based on the raw material?
7. What is the breakup of the global empty capsules market based on the functionality?
8. What is the breakup of the global empty capsules market based on the end user?
9. What are the key regions in the global empty capsules market?
10. Who are the key players/companies in the global empty capsules market?